Phase 3 Trial of Bavencio in Ovarian Cancer is Terminated
News
The immune checkpoint inhibitor Bavencio (avelumab) — given in combination and/or after platinum-based chemotherapy — is no better than chemotherapy alone at delaying disease progression or death in previously untreated women with ... Read more